| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |